TipRanks
Go Ultimate55% OFF

Christopher Hite Insider Profile

4 Followers

Christopher Hite, EVP & Chairman, Partnering at Royalty Pharma, holds 293.60K shares in Royalty Pharma (Ticker: RPRX), holds 0.00 shares in Acceleron Pharma (Ticker: XLRN), holds ― shares in Vera Therapeutics (Ticker: VERA).

Christopher Hite's Trading History

RPRX
Royalty Pharma
Sep 24, 2026EVP & Chairman, PartneringUninformative Sell5.85M$19.72M
XLRN
Acceleron Pharma
Nov 22, 2021―Uninformative Sell―$0.00
KLRA
Kailera Therapeutics, Inc.
―Director――
VERA
Vera Therapeutics
―Director――

You May Also Like

Christopher Hite insider profile FAQ

What stocks does Christopher Hite hold?
Christopher Hite holds: RPRX, XLRN, VERA, KLRA stocks.
What was Christopher Hite’s latest transaction?
Christopher Hite’s latest transaction was an Uninformative Sell of $5.85M.
What is Christopher Hite's role in Royalty Pharma?
Christopher Hite's role in Royalty Pharma is EVP & Chairman, Partnering.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.